A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion

被引:10
作者
Fichter, Christiane Daniela [1 ,2 ,3 ]
Przypadlo, Camilla Maria [1 ,2 ]
Buck, Achim [4 ]
Herbener, Nicola [1 ,2 ]
Riedel, Bianca [1 ,2 ]
Schaefer, Luisa [1 ,2 ]
Nakagawa, Hiroshi [5 ]
Walch, Axel [4 ]
Reinheckel, Thomas [2 ,6 ,7 ,8 ,9 ,10 ]
Werner, Martin [1 ,2 ,7 ,9 ,10 ]
Lassmann, Silke [1 ,2 ,3 ,7 ,8 ,9 ,10 ]
机构
[1] Univ Freiburg, Inst Surg Pathol, Med Ctr, Breisacherstr 115a, D-79106 Freiburg, Germany
[2] Univ Freiburg, Fac Med, Freiburg, Germany
[3] Univ Freiburg, Fac Biol, Freiburg, Germany
[4] Helmholtz Zentrum Munchen, Res Unit Analyt Pathol, Neuherberg, Germany
[5] Univ Penn, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA
[6] Univ Freiburg, Inst Mol Med & Cell Res, Freiburg, Germany
[7] Univ Freiburg, Comprehens Canc Ctr Freiburg, Med Ctr, Freiburg, Germany
[8] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany
[9] German Canc Consortium DKTK, Partner Site Freiburg, Heidelberg, Germany
[10] German Canc Res Ctr, Heidelberg, Germany
关键词
oesophageal cancer; ErbB homodimers; ErbB heterodimers; non-apoptotic blebbing; cell migration; cell invasion; HER-2/NEU GENE AMPLIFICATION; PROTEIN OVEREXPRESSION; IN-VITRO; CANCER; EXPRESSION; MIGRATION; EGFR; ASSOCIATION; CARCINOMA; P63;
D O I
10.1002/path.4987
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Oesophageal squamous cell carcinomas and oesophageal adenocarcinomas show distinct patterns of ErbB expression and dimers. The functional effects of specific ErbB homodimers or heterodimers on oesophageal (cancer) cell behaviour, particularly invasion during early carcinogenesis, remain unknown. Here, a new cellular model system for controlled activation of epidermal growth factor receptor (EGFR) or human epidermal growth factor receptor 2 (HER2) and EGFR-HER2 or HER2-human epidermal growth factor receptor 3 (HER3) homodimers and heterodimers was studied in non-neoplastic squamous oesophageal epithelial Het-1A cells. EGFR, HER2 and HER3 intracellular domains (ICDs) were fused to dimerization domains (DmrA/DmrA and DmrC), and transduced into Het-1A cells lacking ErbB expression. Dimerization of EGFR, HER2 or EGFR-HER2 and HER2-HER3 ICDs was induced by synthetic ligands (A/A or A/C dimerizers). This was accompanied by phosphorylation of the respective EGFR, HER2 and HER3 ICDs and activation of distinct downstream signalling pathways, such as phospholipase C1, Akt, STAT and Src family kinases. Phenotypically, ErbB dimers caused cell rounding and non-apoptotic blebbing, specifically in EGFR-HER2 and HER2-HER3 heterodimer cells. In a Transwell assay, cell migration velocity was elevated in HER2 dimer cells as compared with empty vector cells. In addition, HER2 dimer cells showed in increased cell invasion, reaching significance for induced HER2-HER3 heterodimers (P=0.015). Importantly, in three-dimensional organotypic cultures, empty vector cells grew as a superficial cell layer, resembling oesophageal squamous epithelium. In contrast, induced HER2 homodimer cells were highly invasive into the matrix and formed cell clusters. This was associated with partial loss of cytokeratin 7 (when HER2 homodimers were modelled) and p63 (when EGFR-HER2 heterodimers were modelled), which suggests a change or loss of squamous cell differentiation. Controlled activation of specific EGFR, HER2 and HER3 homodimers and heterodimers caused oesophageal squamous epithelial cell migration and/or invasion, especially in a three-dimensional microenvironment, thereby functionally identifying ErbB homodimers and heterodimers as important drivers of oesophageal carcinogenesis. Copyright (c) 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:481 / 495
页数:15
相关论文
共 50 条
  • [41] Cell Internalization in Fluidic Culture Conditions Is Improved When Microparticles Are Specifically Targeted to the Human Epidermal Growth Factor Receptor 2 (HER2)
    Mora-Espi, Inmaculada
    Ibanez, Elena
    Soriano, Jorge
    Nogues, Carme
    Gudjonsson, Thorarinn
    Barrios, Leonardo
    [J]. PHARMACEUTICS, 2019, 11 (04)
  • [42] A gallium telluride quantum dots bioelectrode system for human epidermal growth factor receptor-2 (Her2/neu) oncogene signalling
    Fuku, Xolile
    Singh, Baljit
    Ajayi, Rachel F.
    Jijana, Abongile N.
    Baker, Priscilla
    Dempsey, Eithne
    Iwuoha, Emmanuel
    [J]. ANALYTICAL METHODS, 2015, 7 (15) : 6114 - 6124
  • [43] Quantitative parameters of magnetic resonance imaging cannot predict human epidermal growth factor receptor 2 (HER2) status in rectal cancer
    Huang, Zhenhuan
    Tu, Xuezhao
    Lin, Qi
    Zhan, Zejuan
    Li, Ying
    Liu, Jinkai
    [J]. CLINICAL IMAGING, 2022, 83 : 77 - 82
  • [44] Human epidermal growth factor receptor 2 overexpression is frequently discordant between primary and metastatic urothelial carcinoma and is associated with intratumoral human epidermal growth factor receptor 2 heterogeneity
    Grigg, Claud M.
    Livasy, Chad
    He, Jiaxian
    Hartman, Aaron
    Clark, Peter E.
    Zhu, Jason
    Raghavan, Derek
    Burgess, Earle F.
    [J]. HUMAN PATHOLOGY, 2021, 107 : 96 - 103
  • [45] Impact of Human Epidermal Growth Factor Receptor 2 (HER2) Low Status in Response to Neoadjuvant Chemotherapy in Early Breast Cancer
    Alves, Fatima R.
    Gil, Lucia
    de Matos, Leonor Vasconcelos
    Baleiras, Ana
    Vasques, Carolina
    Neves, Maria Teresa
    Ferreira, Andre
    Fontes-Sousa, Mario
    Miranda, Helena
    Martins, Ana
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [46] Selection of DNA aptamers for extra cellular domain of human epidermal growth factor receptor 2 to detect HER2 positive carcinomas
    Sett, A.
    Borthakur, B. B.
    Bora, U.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (08) : 976 - 988
  • [47] Human Epidermal Growth Factor Receptor 2-Subtype Invasive Ductal Carcinoma Recurring as Basal-Human Epidermal Growth Factor Receptor 2-Subtype Squamous Cell Carcinoma
    An, Jeongshin
    Yoo, Youngeun
    Kim, Hyun Goo
    Woo, Joohyun
    Lee, Kyoung Eun
    Kwon, Hyungju
    Lim, Woosung
    Sung, Sun Hee
    Paik, Nam Sun
    Moon, Byung-In
    [J]. JOURNAL OF BREAST CANCER, 2019, 22 (03) : 484 - 490
  • [48] Pertuzumab increases epidermal growth factor receptor down-regulation by counteracting epidermal growth factor receptor-ErbB2 heterodimerization
    Hughes, Juliana Bentes
    Berger, Christian
    Rodland, Marianne Skeie
    Hasmann, Max
    Stang, Espen
    Madshus, Inger Helene
    [J]. MOLECULAR CANCER THERAPEUTICS, 2009, 8 (07) : 1885 - 1892
  • [49] Mind the target: human epidermal growth factor receptor 2 in colorectal cancer
    Saude-Conde, Rita
    Rasschaert, Gertjan
    Bregni, Giacomo
    Hendlisz, Alain
    Sclafani, Francesco
    [J]. CURRENT OPINION IN ONCOLOGY, 2022, 34 (04) : 382 - 388
  • [50] Significance of human epidermal growth factor receptor 2 expression in colorectal cancer
    Tu, Jinhua
    Yu, Yinghao
    Liu, Wei
    Chen, Shunping
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 9 (01) : 17 - 24